Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma

NCT00450307 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: monoclonal antibody 3F8
BIOLOGICAL: sargramostim

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]